Conservative surgery not inferior to nephrectomy

Apr 19, 2010

The latest results from the European Organisation for Research and Treatment of Cancer (EORTC) 30904 study were presented in a plenary session today at the Anniversary EAU Congress, which showed that conservative surgery is not inferior to radical renal surgery or nephrectomy.

"Few patients progressed during the study, nine in the radical arm and 12 in the conservative arm," Prof. Hein van Poppel said in his concluding remarks. Van Poppel issued the EORTC results during the plenary session on , a study which examined partial versus radical nephrectomy in .

The EORTC 30904 study involved 541 patients who were randomised, 273 in the radical arm and 268 treated with conservative surgery. Four patients were clinically ineligible, whilst 139 patients were pathologically ineligible. The median follow-up was around 9.3 years.

Amongst the study's pertinent findings were:

  • Few patients progressed during the study, nine in the radical arm and 12 in the conservative arm
  • 117 deaths
12 due to RCC: 4 in radical and 8 in conservative

3 due to surgery: 1 in radical and 2 in conservative

  • Overall survival (OS) is shorter on the conservative arm for all randomized patients (p=0.032)
  • OS of RCC patients is not different (p=0.072)
  • OS of Clinically and pathologically eligible patients is not different (p=0.173)
  • Side effects: nephron-sparing surgery is safe with a slightly higher complication rate than after radical nephrectomy

Explore further: Face transplants change lives, identity

Provided by European Association of Urology

not rated yet
add to favorites email to friend print save as pdf

Related Stories

How less can be more when treating some kidney cancers

Jan 09, 2008

A new Mayo Clinic study suggests that removing the entire kidney from younger patients with small kidney tumors may lead to decreased overall survival compared with an operation that removes the tumor but leaves the kidney ...

Recommended for you

Face transplants change lives, identity

15 hours ago

Patients are prepared to take significant risks in order to be considered for a face transplant, says Dr David Koppel, director of the largest craniofacial unit in the UK and Honorary Clinical Associate Professor ...

British Lords hold ten-hour debate on assisted dying

Jul 19, 2014

Members of Britain's unelected House of Lords spent almost ten hours on Friday discussing whether to legalise assisted dying, in an often emotional debate putting the question back on the agenda, if not on the statute books.

AbbVie, Shire agree on $55B combination

Jul 18, 2014

The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home.

User comments : 0